MANGOCEUTICALS, INC. Operating Income Loss

Quick Answer

MANGOCEUTICALS, INC. reported Operating Income Loss of -$7.97 million for the year ending 2024.

  • MANGOCEUTICALS, INC. showed an increase of +13.5% in Operating Income Loss from 2023 to 2024.
  • This data is from MANGOCEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 20, 2025.
  • XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2022 to 2024), MANGOCEUTICALS, INC.'s Operating Income Loss has declined by 300.3%.
  • Historical annual values: Fiscal year 2024: -$7.97 million | Fiscal year 2023: -$9.22 million | Fiscal year 2022: -$1.99 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: